It is manufactured by the Chiesi Pharmaceuticals (Pvt) Ltd. The main ingredient present in it is the Poractant Alfa which works same as the human surfactant. Its drug category is pulmonary surfactants. It is used to treat respiratory distress syndrome (RDS). It is available in injection form. Its consumer type is parenteral.
A prescription is required for its usage. It will be given to your baby in a hospital by a trained healthcare professional.. In some cases it causes low blood pressure, slow heart rate, low blood oxygen level and blockage of the tube.
|
Manufactured By |
Chiesi Pharmaceuticals (Pvt) Ltd |
|
Product form |
injection |
|
Ingredients |
Poractant Alfa |
|
Storage |
2-8 degrees |
|
Prescription |
required |
|
Age |
Premature infants |
- It is used for the treatment of respiratory distress syndrome.
- Used to treat premature infants
- A proper prescription required for usage of this medicine
- Store in a cool place away from sunlight
- Keep away from the reach of the children
- Bradycardia
- Hypotension
- endotracheal tube blockage
- oxygen desaturation
How does this injection curosurf work?
It contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will help your baby to breathe normally until your baby produces their own surfactant.
Is it safe to use this injection in all premature babies?
No, it is not necessary to use in all premature babies. It can be used only in premature infants suffering from a disease called respiratory distress syndrome (RDS).
What is Poractant Alfa used for?
Poractant Alfa is used to treat or prevent lung distress in premature babies.